Correlación etiopatogénica entre periodontitis y artritis reumatoide

María Victoria Hernández Cuéllar, Isabel María Hernández Cuéllar, Roberto Amaro Hernández

Texto completo:

PDF HTML

Resumen

La artritis reumatoide y la periodontitis crónica y agresiva son enfermedades inflamatorias crónicas caracterizadas por una disregulación de la respuesta inflamatoria en un huésped inmunogenéticamente susceptible. La intensa secreción de mediadores inflamatorios condiciona la destrucción del tejido sinovial y periodontal respectivamente. Ambas enfermedades comparten factores de riesgo y tienen vías patogénicas comunes que conllevan finalmente a la pérdida de la función y discapacidad. Este artículo discute las posibles interacciones, particularmente relacionadas con el patógeno periodontal Porphyromonas gingivalis, que explicaría la asociación observada entre estas enfermedades de elevada prevalencia en el marco de los más recientes descubrimientos.

Palabras clave

Artritis reumatoide; Periodontitis; Porphyromonas gingivalis

Referencias

Kasser UR, Gleissner C, Dehne F, Michel A,Willershausen-Zonnchen B, Bolten WW. Risk for periodontal disease in patients with longstanding rheumatoid arthritis. Arthritis Rheum. 1997;40:2248-51.

Mercado F, Marshall RI, Klestov AC, Bartold PM. Is there a relationship between rheumatoid arthritis and periodontal disease? J Clin Periodontol. 2000;27:267-72.

Ogrendik M. Rheumatoid arthritis is linked to oral bacteria: etiological association. Mod Rheumatol. 2009;19:453-6.

Jacqueline Detert, Nicole Pischon, Gerd R Burmester, and Frank Buttgereit The association between rheumatoid arthritis and periodontal disease Arthritis Res Ther. 2010;12(5):218.

Bartold PM, Marshall RI, Haynes DR. Periodontitis and rheumatoid arthritis: a review. J Periodontol. 2005;76(11 Suppl 1):2066-74.

Smolik I, Robinson D, El-Gabalawy HS. Periodontitis and rheumatoid arthritis: epidemiologic, clinical, and immunologic associations.Compend Contin Educ Dent. 2009;30(4):188-90.

Gabriel SE. The epidemiology of rheumatoid arthritis.Rheum Dis Clin North Am. 2001;27:269-81.

Karsten Conrad, Dirk Roggenbuck, Dirk Reinhold and Thomas Dörner Profiling of rheumatoid arthritis associated autoantibodies Autoimmunity Reviews. 2010;9(6):431-5.

Wegner N, Lundberg K, Kinloch A, Fisher B, Malmström V, Feldmann M, Venables PJ. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol Rev. 2010 Jan;233(1):34-54.

Van der Woude D., Huizinga T. W. J..Genetics: Every shared epitope allele for itself? Nature Reviews Rheumatology. 2009;5,477-8.

Irfan UM, Dawson DV, Bissada NF. Epidemiology of periodontal disease: a review and clinical perspectives.J Int Acad Periodontol. 2001;3:14-21.

Takashiba S, Naruishi K, Murayama Y. Perspective of cytokine regulation for periodontal treatment: fibroblast biology. J Periodontol. 2003;74:103-10.

Okada Y, Meguro M, Ohyama H et al. Human leukocyte histocompatibility antigen class II-induced cytokines from human gingival fibroblasts promote proliferation of human umbilical vein endothelial cells: potential association with enhanced angiogenesis in chronic periodontal inflammation. J Periodontal Res. 2009;44:103-9.

Arend WP, Dayer JM. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum. 1990;33:305-15.

Bartold PM, Marshall RI, Haynes DR. Periodontitis and Rheumatoid Arthritis: A Review Journal of Periodontology. 2005:76(11):2066-74.

Gabalawy H. The preclinical stages of RA: lessons from human studies and animal models. Best Pract Res Clin Rheumatol. 2009;23:49-58.

Ogrendik M, Kokino S, Ozdemir F, Bird PS, Hamlet S.Serum antibodies to oral anaerobic bacteria in patients with rheumatoid arthritis. Med Gen Med. 2005;7:2.

Lundberg K, Wegner N, Yucel-Lindberg T, Venables PJ.Periodontitis in RA-the citrullinated enolase connection. Nat Rev Rheumatol. 2010;6:727-30.

Holt SC, Ebersole J, Felton J, Brunsvold M, Kornman KS. Implantation of Bacteroides gingivalis in nonhuman primates initiates progression of periodontitis. Science. 1988;239:55-7.

McGraw WT, Potempa J, Farley D, Travis J. Purification, characterization, and sequence analysis of a potential virulence factor from Porphyromonas gingivalis, peptidylarginine deiminase. Infect Immun. 1999;67:3248-56.

Mangat P, Wegner N, Venables PJ, Potempa J. Bacterial and human peptidylarginine deiminases: targets for inhibiting the autoimmune response in rheumatoid arthritis? Arthritis Res Ther. 2010;12:209.

Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest. 1998;101:273-81.

Girbal-Neuhauser E, Durieux JJ, Arnaud M. The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol. 1999;162:585-94.

Baeten D, Peene I, Union A. Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: relevance to antifilaggrin autoantibodies.Arthritis Rheum. 2001;44:2255-62.

Van Venrooij WJ, Hazes JM, Visser H. Anticitrullinated protein/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis. Neth J Med. 2002;60:383-8.

Mikuls TR, Payne JB, Reinhardt RA. Antibody responses to Porphyromonas gingivalis (P. gingivalis) in subjects with rheumatoid arthritis and periodontitis.Int Immunopharmacol. 2009;9:38-42.

Whitney C, Ant J, Moncla B, Johnson B, Page RC, Engel D. Serum immunoglobulin G antibody to Porphyromonas gingivalis in rapidly progressive periodontitis: titer, avidity, and subclass distribution. Infect Immun. 1992;60:2194-200.

Masson-Bessiere C, Sebbag M, Girbal-Neuhauser. The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J Immunol. 2001;166:4177-84.

Travis J, Pike R, Imamura T, Potempa J. Porphyromonas gingivalis proteinases as virulence factors in the development of periodontitis. J Periodontal Res. 1997;32:120-5.

Szodoray P, Szabo Z, Kapitany A. Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis. Autoimmun Rev. 2009;9:140-3.

Michalowicz BS, Diehl SR, Gunsolley JC. Evidence of a substantial genetic basis for risk of adult periodontitis.J Periodontol. 2000;71:1699-707.

Nepom GT, Nepom BS. Prediction of susceptibility to rheumatoid arthritis by human leukocyte antigen genotyping. Rheum Dis Clin North Am. 1992;18:785-92.

Bonfil JJ, Dillier FL, Mercier P. A ‘‘case control’’ study on the role of HLA DR4 in severe periodontitis and rapidly progressive periodontitis. Identification of types and subtypes using molecular biology (PCR.SSO). J Clin Periodontol. 1999;26:77-84.

Hill JA, Southwood S, Sette A, Jevnikar AM, Bell DA, Cairns E. Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol. 2003;171:538-41.

Berthelot JM, Le Goff B. Rheumatoid arthritis and periodontal disease. Joint Bone Spine. 2010;77(6):537-41.

Li W, Wang M, Irigoyen P, Gregersen PK. Inferring causal relationships among intermediate phenotypes and biomarkers: a case study of rheumatoid arthritis. Bioinformatics. 2006;22:1503-7.

Wipke BT, Wang Z, Nagengast W, Reichert DE, Allen PM. Staging the initiation of autoantibody-induced arthritis: a critical role for immune complexes. J Immunol. 2004;172:7694-702.

Willemze A, Ioan-Facsinay A, El-Gabalawy H. Anti-citrullinated protein antibody response associated with synovial immune deposits in a patient with suspected early rheumatoid arthritis. J Rheumatol. 2008;35:2282-4

Enlaces refback

  • No hay ningún enlace refback.


Copyright (c)